Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Identification and Treatment of Occult Metastatic Disease in Stage III Colon Cancer

NCT03803553 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03803553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03803553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Identification and Treatment of Occult Metastatic Disease in Stage III Colon Cancer
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Active, not recruiting
Start date
April 16, 2020
Completion date
December 31, 2027
Enrollment
400 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colon cancer, stage iii colon cancer